IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7368444 B1

PDFFull Text
Date of Patent:
May. 06, 2008

Filed:

Feb. 13, 2003

N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient

Applicants:

Takuya Seko, Osaka, JP;

Seishi Katsumata, Mishima-gun, JP;

Masashi Kato, Mishima-gun, JP;

Jun-ichiro Manako, Mishima-gun, JP;

Kazuyuki Ohmoto, Mishima-gun, JP;

Inventors:

Takuya Seko, Osaka, JP;

Seishi Katsumata, Mishima-gun, JP;

Masashi Kato, Mishima-gun, JP;

Jun-ichiro Manako, Mishima-gun, JP;

Kazuyuki Ohmoto, Mishima-gun, JP;

Assignee:

Ono Pharmaceutical Co., Ltd., Osaka, JP;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Brenda L Coleman

Int. Cl.
CPC ...
C07D 223/16 (2006.01); C07D 225/06 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01); A61K 31/395 (2006.01); A61K 31/55 (2006.01); A61K 31/553 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to the compound presented by formula (I) (wherein all symbols in formula (I) are the same mean as the description shown in the specification.), mitocondorial benzogeazepin receptor (MBR) antagonist comprising the compound, the preventive and/or treatment medicine against diseases caused by stress of which an active ingredient is the compound. Since the compound represented by formula (I) has MBR antagonistic activity, and controls the production of neurosteroid, it is useful as the preventive and/or treatment medicine against diseases caused by stress.

Find Patent Forward Citations

Loading…